Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition: Candidiasis, InvasiveInterventions: Drug: Caspofungin; Drug: Amphotericin B DeoxycholateSponsor: Merck Sharp & Dohme Corp.Recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials